JOHN STINSON — Lobbyist Profile | Poliscope

JOHN STINSON

Reported covered position: N/A

Filings

Clients

Firms

Years active

2001–2008

Associated filing income

$1,520,000

How to read the money

Income and expense are whole-filing amounts associated with this lobbyist, not personal compensation or an allocated share.

Clients represented

Client	Filings	Years
BARR LABORATORIES	16	2001–2008
AMERICAN ASSOCIATION FOR JUSTICE	2	2003–2004
ARCTIC RESOURCES CO	2	2002
ADVENTIST HEALTH SYSTEM	1	2003

Lobbying firms

Firm	Filings	Years
FORSCEY, PLLC	21	2001–2008

Bills explicitly cited in this lobbyist’s assigned issues (21)

No topic inference: each bill number appears in source LDA issue text assigned to this lobbyist.

H.R. 1038

Access to Life-Saving Medicine Act

Client: BARR LABORATORIES · Firm: FORSCEY, PLLC

Open original LDA filing ↗

Cited source text

Advance proposal to create an FDA processs for the approval of generic biological products. S. 316 - Preserve Access to Affordable Generics Act; H.R. 1902 - Protecting Consumer Access to Generic Drugs Act; H.R. 1038 - Access to Life Saving Medicine Act.

H.R. 1038

Access to Life-Saving Medicine Act

Client: BARR LABORATORIES · Firm: FORSCEY, PLLC

Open original LDA filing ↗

Cited source text

Advance proposal to create an FDA process for the approval of generic biological products; S. 316 - Preserve Access to Affordable Generics Act; H.R. 1902 - Protecting Consumer Access to Generic Drugs Act; H.R. 1038 - Access to Life Saving Medicine Act.

Original LDA source filings (21)

Specific issues are shown only where the LDA source assigned them to this lobbyist. Targets apply to the associated filing.

BARR LABORATORIES via FORSCEY, PLLC

2008 · fourth_quarter · 4@

Firm income: $60,000Client expense: —Open original LDA filing ↗

Assigned issues and filing targets (1 issues)

HCR

Health Issues

Advance proposal to create an FDA process for the approval of generic biological products; S. 316 - Preserve Access to Affordable Generics Act; H.R. 1902 - Protecting Consumer Access to Generic Drugs Act; H.R. 1038 - Access to Life Saving Medicine Act.

Filing targets: HOUSE OF REPRESENTATIVES, SENATE

BARR LABORATORIES via FORSCEY, PLLC

2008 · fourth_quarter · Q4

Source: Senate LDA

Show 17 more cited filings

H.R. 1038

Access to Life-Saving Medicine Act

Client: BARR LABORATORIES · Firm: FORSCEY, PLLC

Open original LDA filing ↗

Cited source text

Advance proposal to create an FDA process for the approval of generic biological products; S. 316 - Preserve Access to Affordable Generics Act; H.R. 1902 - Protecting Consumer Access to Generic Drugs Act; H.R. 1038 - Access to Life Saving Medicine Act.

H.R. 1902

Protecting Consumer Access to Generic Drugs Act of 2007

Client: BARR LABORATORIES · Firm: FORSCEY, PLLC

Open original LDA filing ↗

Cited source text

Advance proposal to create an FDA process for the approval of generic biological products; S. 316 - Preserve Access to Affordable Generics Act; H.R. 1902 - Protecting Consumer Access to Generic Drugs Act; H.R. 1038 - Access to Life Saving Medicine Act.

H.R. 1902

Protecting Consumer Access to Generic Drugs Act of 2007

Client: BARR LABORATORIES · Firm: FORSCEY, PLLC

Open original LDA filing ↗

Cited source text

Advance proposal to create an FDA process for the approval of generic biological products; S. 316 - Preserve Access to Affordable Generics Act; H.R. 1902 - Protecting Consumer Access to Generic Drugs Act; H.R. 1038 - Access to Life Saving Medicine Act.

H.R. 1902

Protecting Consumer Access to Generic Drugs Act of 2007

Client: BARR LABORATORIES · Firm: FORSCEY, PLLC

Open original LDA filing ↗

Cited source text

Advance proposal to create an FDA processs for the approval of generic biological products. S. 316 - Preserve Access to Affordable Generics Act; H.R. 1902 - Protecting Consumer Access to Generic Drugs Act; H.R. 1038 - Access to Life Saving Medicine Act.

H.R. 1902

Protecting Consumer Access to Generic Drugs Act of 2007

Client: BARR LABORATORIES · Firm: FORSCEY, PLLC

Open original LDA filing ↗

Cited source text

Advance proposal to create an FDA process for the approval of generic biological products; S. 316 - Preserve Access to Affordable Generics Act; H.R. 1902 - Protecting Consumer Access to Generic Drugs Act; H.R. 1038 - Access to Life Saving Medicine Act.

H.R. 1902

Protecting Consumer Access to Generic Drugs Act of 2007

Client: BARR LABORATORIES · Firm: FORSCEY, PLLC

Open original LDA filing ↗

Cited source text

Advance proposal to create an FDA processs for the approval of generic biological products. S. 316 - Preserve Access to Affordable Generics Act; H.R. 1902 - Protecting Consumer Access to Generic Drugs Act; H.R. 1038 - Access to Life Saving Medicine Act.

S. 316

Preserve Access to Affordable Generics Act

Client: BARR LABORATORIES · Firm: FORSCEY, PLLC

Open original LDA filing ↗

Cited source text

Advance proposal to create an FDA process for the approval of generic biological products; S. 316 - Preserve Access to Affordable Generics Act; H.R. 1902 - Protecting Consumer Access to Generic Drugs Act; H.R. 1038 - Access to Life Saving Medicine Act.

S. 316

Preserve Access to Affordable Generics Act

Client: BARR LABORATORIES · Firm: FORSCEY, PLLC

Open original LDA filing ↗

Cited source text

Advance proposal to create an FDA process for the approval of generic biological products; S. 316 - Preserve Access to Affordable Generics Act; H.R. 1902 - Protecting Consumer Access to Generic Drugs Act; H.R. 1038 - Access to Life Saving Medicine Act.

S. 316

Preserve Access to Affordable Generics Act

Client: BARR LABORATORIES · Firm: FORSCEY, PLLC

Open original LDA filing ↗

Cited source text

Advance proposal to create an FDA processs for the approval of generic biological products. S. 316 - Preserve Access to Affordable Generics Act; H.R. 1902 - Protecting Consumer Access to Generic Drugs Act; H.R. 1038 - Access to Life Saving Medicine Act.

S. 316

Preserve Access to Affordable Generics Act

Client: BARR LABORATORIES · Firm: FORSCEY, PLLC

Open original LDA filing ↗

Cited source text

Advance proposal to create an FDA process for the approval of generic biological products; S. 316 - Preserve Access to Affordable Generics Act; H.R. 1902 - Protecting Consumer Access to Generic Drugs Act; H.R. 1038 - Access to Life Saving Medicine Act.

S. 316

Preserve Access to Affordable Generics Act

Client: BARR LABORATORIES · Firm: FORSCEY, PLLC

Open original LDA filing ↗

Cited source text

Advance proposal to create an FDA processs for the approval of generic biological products. S. 316 - Preserve Access to Affordable Generics Act; H.R. 1902 - Protecting Consumer Access to Generic Drugs Act; H.R. 1038 - Access to Life Saving Medicine Act.

H.R. 1038

Access to Life-Saving Medicine Act

Client: BARR LABORATORIES · Firm: FORSCEY, PLLC

Open original LDA filing ↗

Cited source text

S 316 - Preserve Access to Affordable Generics Act HR 1902 - Protecting Consumer Access to Generic Drugs Act HR 1038 - Access to Life-Saving Medicine Act S 1082 - Prescription Drug User Fee Act of 2007

H.R. 1432

Preserve Access to Affordable Generics Act

Client: BARR LABORATORIES · Firm: FORSCEY, PLLC

Open original LDA filing ↗

Cited source text

HR.1432 - Preserve Access to Affordable Generics Act S. 1082 - Prescription Drug User Fee Amendments of 2007, Generic Biologics S.1145 - Patent Reform Act of 2007 HR.1908 - Patent Reform Act of 2007 Amendment SA 1025 (S. 1082) - To express the sense of the Senate with respect to follow-on biologics

H.R. 1902

Protecting Consumer Access to Generic Drugs Act of 2007

Client: BARR LABORATORIES · Firm: FORSCEY, PLLC

Open original LDA filing ↗

Cited source text

S 316 - Preserve Access to Affordable Generics Act HR 1902 - Protecting Consumer Access to Generic Drugs Act HR 1038 - Access to Life-Saving Medicine Act S 1082 - Prescription Drug User Fee Act of 2007

H.R. 1908

Patent Reform Act of 2007

Client: BARR LABORATORIES · Firm: FORSCEY, PLLC

Open original LDA filing ↗

Cited source text

HR.1432 - Preserve Access to Affordable Generics Act S. 1082 - Prescription Drug User Fee Amendments of 2007, Generic Biologics S.1145 - Patent Reform Act of 2007 HR.1908 - Patent Reform Act of 2007 Amendment SA 1025 (S. 1082) - To express the sense of the Senate with respect to follow-on biologics

S. 1145

Patent Reform Act of 2007

Client: BARR LABORATORIES · Firm: FORSCEY, PLLC

Open original LDA filing ↗

Cited source text

HR.1432 - Preserve Access to Affordable Generics Act S. 1082 - Prescription Drug User Fee Amendments of 2007, Generic Biologics S.1145 - Patent Reform Act of 2007 HR.1908 - Patent Reform Act of 2007 Amendment SA 1025 (S. 1082) - To express the sense of the Senate with respect to follow-on biologics

S. 316

Preserve Access to Affordable Generics Act

Client: BARR LABORATORIES · Firm: FORSCEY, PLLC

Open original LDA filing ↗

Cited source text

S 316 - Preserve Access to Affordable Generics Act HR 1902 - Protecting Consumer Access to Generic Drugs Act HR 1038 - Access to Life-Saving Medicine Act S 1082 - Prescription Drug User Fee Act of 2007

Show 17 more original filings

BARR LABORATORIES via FORSCEY, PLLC

2008 · first_quarter · Q1

Firm income: $60,000Client expense: —Open original LDA filing ↗

Assigned issues and filing targets (1 issues)

HCR

Health Issues

Advance proposal to create an FDA processs for the approval of generic biological products. S. 316 - Preserve Access to Affordable Generics Act; H.R. 1902 - Protecting Consumer Access to Generic Drugs Act; H.R. 1038 - Access to Life Saving Medicine Act.

Filing targets: HOUSE OF REPRESENTATIVES, SENATE

BARR LABORATORIES via FORSCEY, PLLC

2007 · year_end · YY

Firm income: $120,000Client expense: —Open original LDA filing ↗

Assigned issues and filing targets (1 issues)

HCR

Health Issues

S 316 - Preserve Access to Affordable Generics Act HR 1902 - Protecting Consumer Access to Generic Drugs Act HR 1038 - Access to Life-Saving Medicine Act S 1082 - Prescription Drug User Fee Act of 2007

Filing targets: HOUSE OF REPRESENTATIVES, SENATE

BARR LABORATORIES via FORSCEY, PLLC

2007 · mid_year · MM

Firm income: $100,000Client expense: —Open original LDA filing ↗

Assigned issues and filing targets (1 issues)

HCR

Health Issues

HR.1432 - Preserve Access to Affordable Generics Act S. 1082 - Prescription Drug User Fee Amendments of 2007, Generic Biologics S.1145 - Patent Reform Act of 2007 HR.1908 - Patent Reform Act of 2007 Amendment SA 1025 (S. 1082) - To express the sense of the Senate with respect to follow-on biologics

Filing targets: HOUSE OF REPRESENTATIVES, SENATE

BARR LABORATORIES via FORSCEY, PLLC

2006 · year_end · YY

Firm income: $60,000Client expense: —Open original LDA filing ↗

Assigned issues and filing targets (1 issues)

HCR

Health Issues

Prescription Drug Reimportation Legislation Regulatory Approval of Biogeneric Pharmaceutical Products Bioshield II H.R. 2795, Patent Reform Act

Filing targets: HOUSE OF REPRESENTATIVES, SENATE

BARR LABORATORIES via FORSCEY, PLLC

2006 · mid_year · MM

Firm income: $60,000Client expense: —Open original LDA filing ↗